Ipilimumab vs Ramipril
Ipilimumab vs Ramipril: Overview
This comparison examines the pharmacological differences between Ipilimumab and Ramipril.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Ramipril: Prodrug converted to ramiprilat; ACE inhibitor.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Ramipril β 13-17 hours.
Chemical Properties
Molecular Formula: Ramipril β C23H32N2O5.
Molecular Weight: Ramipril β 416.5120 g/mol.
Type: Ipilimumab β Antibody; Ramipril β Small molecule.